Graham Gerard J, McKimmie Clive S
Division of Immunology, Infection and Inflammation, University of Glasgow, G12 8TA, UK.
Trends Immunol. 2006 Aug;27(8):381-6. doi: 10.1016/j.it.2006.06.006. Epub 2006 Jun 30.
The atypical chemokine receptor, D6, is efficient at sequestering and scavenging inflammatory CC chemokines. The absence of D6 blocks the successful resolution of immune responses in models of inflammation, suggesting that CC-chemokine scavenging by D6 is an important component of the resolution phase of in vivo inflammatory responses. Most studies have suggested that lymphatic endothelial cells are the main vehicles for D6 function in vivo. Here, we propose that leukocytes, which also express D6, could be more-effective vehicles for D6 scavenging function. Thus, leukocytes might be the primary cell type that removes inflammatory chemokines from inflamed tissues. We also propose that lymphatic endothelial cell-expressed D6 might have a distinct but complementary role in restricting inflammatory leukocyte access to the lymphatic vasculature.
非典型趋化因子受体D6能够有效地隔离和清除炎症CC趋化因子。在炎症模型中,D6的缺失会阻碍免疫反应的成功消退,这表明D6对CC趋化因子的清除是体内炎症反应消退阶段的一个重要组成部分。大多数研究表明,淋巴管内皮细胞是D6在体内发挥功能的主要载体。在此,我们提出,同样表达D6的白细胞可能是D6清除功能更有效的载体。因此,白细胞可能是从炎症组织中清除炎症趋化因子的主要细胞类型。我们还提出,淋巴管内皮细胞表达的D6在限制炎症白细胞进入淋巴管系统方面可能具有独特但互补的作用。